IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells. (Q52016952)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells. |
scientific article |
Statements
IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells. (English)
1 reference
Bathe OF
1 reference
Dalyot-Herman N
1 reference
Malek TR
1 reference
1 October 2001
1 reference
167
1 reference
8
1 reference
4511-4517
1 reference
Identifiers
1 reference